Medicale Corp. Files 8-K for Accountant Change & Financials

Ticker: MCLE · Form: 8-K · Filed: Dec 31, 2024 · CIK: 1827855

Sentiment: neutral

Topics: auditor-change, financial-statements

TL;DR

Medicale Corp. filed an 8-K on 12/31/24 for auditor change and financials.

AI Summary

Medicale Corp. filed an 8-K on December 31, 2024, to report changes in its certifying accountant and to file financial statements and exhibits. The company, incorporated in Nevada, has its principal executive offices in Wellington, Florida.

Why It Matters

This filing indicates a change in the company's auditor and the submission of financial documents, which are crucial for investors to assess the company's financial health and compliance.

Risk Assessment

Risk Level: low — This is a routine filing for changes in certifying accountant and submission of financial statements, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report changes in Medicale Corp.'s certifying accountant and to file financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on December 31, 2024.

In which state is Medicale Corp. incorporated?

Medicale Corp. is incorporated in Nevada.

What is Medicale Corp.'s principal executive office address?

Medicale Corp.'s principal executive office is located at 9314 Forest Hill Blvd #929, Wellington, FL 33411.

What is Medicale Corp.'s telephone number?

Medicale Corp.'s telephone number is (407) 245-7339.

Filing Stats: 831 words · 3 min read · ~3 pages · Grade level 14.9 · Accepted 2024-12-31 08:36:36

Filing Documents

01. Change in Registrant's Certifying Accountant

Item 4.01. Change in Registrant's Certifying Accountant. (a) Dismissal of Former Independent Registered Public Accounting Firm On December 31, 2024, the Board of Directors of Medicale Corp. (the "Company") approved the dismissal of GreenGrowth CPAs ("Greengrowth") as the Company's independent registered public accounting firm, effective immediately. Greengrowth's reports on the Company's financial statements as of and for the year ended September 30, 2023contained no adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except to indicate that there is doubt as to their ability to continue as a going concern In connection with the audits of the Company's consolidated financial statements for the fiscal years ended September 30, 2023, and in the subsequent interim period through June 30, 2024, there were no disagreements with Greengrowthon any matters of accounting principles or practices, financial statement disclosure or auditing scope and procedures which, if not resolved to the satisfaction of Greengrowth, would have caused Greengrowthto make reference to the matter in their report. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the fiscal year ended September 30, 2023, or in the subsequent interim period through June 30, 2024. In accordance with Item 304(a)(3) of Regulation S-K, on December 31, 2024, the Company provided Greengrowthwith a copy of the foregoing disclosures and requested that Greengrowthprovide a letter addressed to the SEC stating whether it agrees with such disclosures. A copy of Greengrowth'sletter dated December 31, 2024is filed as Exhibit 16.1 to this Current Report on Form 8-K. (b) Appointment of New Independent Registered Public Accounting Firm On December 31, 2024, the Board of Directors of the Company approved the appointment of Victor Mokuolu, CPA PLLC ("VMCPA") as the Company's new indepen

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 16.1 Letter from GreenGrowth CPAs, dated December 31, 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medicale Corp. Date: December 31, 2024 By: /s/ Chen Zu De Name: Chen Zu De Title: Chief Executive Officer Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing